|
OHB 1 |
OHB 2 |
OHB 3 |
OHB
4 |
Gender / Age (years) |
Male/56 |
Male /33 |
Male /23 |
Male
/37 |
ART regimen |
TDF/FTC+DTG |
TAF/FTC+ COBİSİSTAT+EVG |
TDF/FTC+DTG |
TAF/FTC+ COBİSİSTAT+EVG |
ART usage period (years) |
8 |
2 |
4 |
3 |
HBsAg |
NEGATİF |
NEGATİF |
NEGATİF |
NEGATİF |
Anti HBs |
NEGATİF |
POZİTİF |
NEGATİF |
POZİTİF |
Anti HBc IgG |
POZİTİF |
POZİTİF |
|
POZİTİF |
HBV DNA (IU/ml) |
60 |
924 |
1128 |
932 |
HIV RNA (copies / ml) |
285000 |
14000 |
2090 |
1287 |
Delta Antibody |
Normal |
Normal |
Normal |
Normal |
CD4 count (cell/ mm3) |
433 |
199 |
200 |
235 |
Hemoglobin (g/dL) |
14,8 |
13 |
13 |
15 |
Leukocyte (10³ / µL) |
7500 |
7200 |
5100 |
5300 |
Platelet (10³ / µL) |
287000 |
119 |
121 |
231 |
ALT (U/L) |
18 |
34 |
34 |
34 |
AST (U/L) |
22 |
44 |
54 |
44 |
ALP (U/L) |
69 |
56 |
181 |
220 |
Total bilüribin (mg/dl) |
0,4 |
1,2 |
1,2 |
1,2 |
Albümin (g/dl) |
N/A |
3,2 |
2,9 |
2,9 |
USG |
Normal |
Normal |
Normal |
Normal |